Overview

A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)

Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
To compare the bronchodilator efficacy of ipratropium plus salbutamol (Combivent) with salbutamol alone given every 20 minutes for three doses in asthmatic children with severe acute exacerbation
Phase:
Phase 4
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Albuterol
Ipratropium